STOCK TITAN

National Health Investors Stock Price, News & Analysis

NHI NYSE

Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.

National Health Investors, Inc. (NHI) provides essential updates for stakeholders tracking this healthcare-focused REIT. This page aggregates official announcements and strategic developments related to senior housing financing, medical facility transactions, and operational partnerships.

Investors and analysts will find timely updates on earnings reports, property acquisitions, and joint venture formations, along with regulatory filings and dividend declarations. The curated news flow emphasizes NHI's core activities in sale-leaseback transactions and specialty hospital financing.

Bookmark this page to monitor NHI's progress in capitalizing on aging population trends through its diversified portfolio of assisted living communities, memory care facilities, and skilled nursing properties. Check regularly for insights into how the company balances stable rental income with growth-oriented mezzanine financing strategies.

Rhea-AI Summary

National Health Investors (NYSE:NHI) announced the preliminary results of its 2025 Annual Meeting of Stockholders, where shareholders elected all four of the company's director nominees: Robert G. Adams, Robert W. Chapin, Jr., James R. Jobe, and Candice W. Todd. The company acknowledged the constructive dialogue with stockholders and highlighted recent corporate governance improvements, including the declassification of its Board. NHI expressed confidence in its strategy to generate superior total shareholder return while recognizing the need for continued improvements. The company has retained Hogan Lovells US LLP as legal counsel and Sodali & Co. as proxy solicitor. Final voting results will be filed with the SEC on Form 8-K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
-
News
Rhea-AI Summary
NHI (NYSE:NHI) has issued a response to ISS's recent recommendation regarding board nominations. The company strongly disagrees with ISS's recommendation to support Land & Buildings nominees, arguing it could disrupt NHI's momentum in the senior housing industry. NHI emphasizes their superior total shareholder return (TSR) and operational performance, including over $400 million in dispositions of underperforming assets during the pandemic. The company highlights that current nominees Robert G. Adams and James R. Jobe possess critical industry experience, while L&B's nominees lack relevant operational experience. NHI points to recent governance improvements, including adding 5 new independent directors in 5 years and forming a Special Committee for NHC lease negotiations. The company urges shareholders to vote "FOR" NHI's director nominees on the WHITE proxy card at the upcoming May 21, 2025 Annual Meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
none
-
News
Rhea-AI Summary
National Health Investors (NYSE: NHI) announced on May 5, 2025 that it has released an investor update, which can be accessed through their investor relations website. The update is available at https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx. No specific details about the contents of the update were provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
none
Rhea-AI Summary

National Health Investors (NYSE:NHI) has declared its second quarter dividend for 2025. The company will distribute a dividend of $0.90 per common share to shareholders. The dividend will be paid on August 1, 2025, to stockholders who are on record as of June 30, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
dividends earnings
-
News
Rhea-AI Summary
National Health Investors (NYSE:NHI) reported strong Q1 2025 results with net income per diluted share of $0.74, up from $0.71 year-over-year. The company increased its 2025 guidance, with NAREIT FFO now projected at $4.64-$4.70 per share. Key Q1 highlights include: • Rental income up 10.7% ($6.7M increase) • SHOP segment NOI of $3.1M, up 4.9% YoY • Normalized FAD increased to $56.0M from $51.0M Notable portfolio activity includes $174.9M in year-to-date investments at an 8.2% average initial yield, with a pipeline of approximately $264.0M. Major acquisitions include a $46.3M assisted living facility in New Jersey and a $63.5M portfolio of six memory care communities in Nebraska. The company maintains a strong balance sheet with $1.3B in net debt and investment-grade ratings. Occupancy rates remain stable across properties, with SHOP facilities at 88.9% as of March 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
-
Rhea-AI Summary

National Health Investors (NYSE:NHI) has announced a change in the timing of its first quarter 2025 earnings conference call and webcast. The event has been rescheduled from 11:00 a.m. to 10:00 a.m. Eastern Time on Tuesday, May 6, 2025. The company will release its earnings report after market close on Monday, May 5, 2025.

Investors can participate in the interactive teleconference by calling (888) 506-0062 with access code 111859. A live broadcast will be available online at www.nhireit.com and through the company's webcasting platform, with an online replay remaining accessible for one year after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
conferences earnings
Rhea-AI Summary

National Health Investors (NYSE:NHI) has mailed a letter to stockholders ahead of its May 21, 2025 Annual Meeting, urging them to vote 'FOR' four Board nominees on the WHITE proxy card. The letter highlights NHI's superior shareholder returns, with the company outperforming key REIT indices over 1-year, 3-year, and 5-year periods through December 31, 2024.

The company has significantly refreshed its Board since May 2020, adding six new members and increasing Board diversity from 0% to 37.5%. Notable achievements include reducing average tenure from 21 to 7 years and appointing new committee chairs. A Special Committee of Non-Interested Directors has been formed to oversee lease negotiations with National Healthcare (NHC), which represents 14% of NHI's 2024 NOI.

The letter addresses Land & Buildings' (L&B) proxy contest, which owns 1.3% of shares and nominated candidates to replace two board members. NHI's Board argues that L&B's candidates do not add value to the current Board's skill sets and that L&B has not proposed substantive ideas for improvement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
none
-
Rhea-AI Summary

National Health Investors (NYSE:NHI) has scheduled its first quarter 2025 earnings release and conference call. The company will release its financial results for Q1 2025 (ended March 31) after market close on Monday, May 5, 2025.

A conference call to discuss the results will be held the following day, Tuesday, May 6, 2025, at 11:00 a.m. Eastern Time. Investors can participate in the interactive teleconference by calling (888) 506-0062 with access code 111859. The call will also be broadcast live online at www.nhireit.com, with a replay available for one year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
conferences earnings
-
Rhea-AI Summary

Land & Buildings Investment Management, a significant stockholder of National Health Investors (NHI), has filed definitive proxy materials and sent a letter to stockholders advocating for boardroom change at the upcoming 2025 Annual Meeting on May 21, 2025.

The activist investor is nominating two independent candidates - Adam Troso and Jim Hoffmann - citing concerns over NHI's corporate governance and conflicts of interest, particularly regarding ongoing lease renewal negotiations with major tenant National Healthcare Corp (NHC).

Key issues highlighted include:

  • NHI's significant underperformance: -61% vs peers over 5 years, -19% over 3 years, and -27% over 1 year
  • Potential 60% upside in NHC lease renewal, representing approximately $0.55/share or 12% FFO/share increase
  • Forecast of $1 billion in senior housing acquisitions over next 12-24 months, potentially increasing FFO/share by 10%
  • Board conflicts including multiple directors' significant stock ownership in tenant NHC

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
none
Rhea-AI Summary

National Health Investors (NYSE:NHI) has filed definitive proxy materials for its Annual Meeting scheduled for May 21, 2025. The company is urging stockholders to vote 'FOR' four board nominees amid a challenge from activist hedge fund Land & Buildings (L&B), which owns 1.3% of shares.

NHI reported strong performance in 2024 with a 30.6% total shareholder return (TSR), outperforming the Nareit Healthcare REIT Index. The company achieved $235 million in investments at an 8.6% average yield and has already closed $136.4 million in investments in 2025.

Key highlights include: board refreshment with four new members in four years, commitment to remove classified board structure, creation of a Special Committee for NHC lease negotiations, and improved financial metrics including a 32% increase in Senior Housing Operating Portfolio NOI. The company raised approximately $278.4 million in equity proceeds, with $68.9 million remaining available as of March 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
none

FAQ

What is the current stock price of National Health Investors (NHI)?

The current stock price of National Health Investors (NHI) is $75.35 as of October 17, 2025.

What is the market cap of National Health Investors (NHI)?

The market cap of National Health Investors (NHI) is approximately 3.5B.
National Health Investors

NYSE:NHI

NHI Rankings

NHI Stock Data

3.49B
46.44M
2.17%
75.08%
3.84%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
MURFREESBORO